# Differences in Itch Quality Between Interleukin-31 and Thymus and Activation-Regulated Chemokine of Japanese Atopic Dermatitis

**Authors:** Yozo Ishiuji, Minako Ogawa-Tominaga, Michie Katsuta, Itaru Dekio, Shiho Kawagoe, Yoko Kobayashi, Yoshimasa Nobeyama, Budiman Kharma, Hiroshi Kawasaki, Toshiya Ebata, Motoki Morita, Mitsutoshi Tominaga, Kenji Takamori, Akihiko Asahina

PMC · DOI: 10.1016/j.mayocpiqo.2026.100695 · Mayo Clinic Proceedings: Innovations, Quality & Outcomes · 2026-02-20

## TL;DR

This study explores how different types of itch in atopic dermatitis patients relate to specific blood biomarkers like IL-31 and TARC.

## Contribution

The study identifies distinct itch qualities linked to IL-31 and TARC in Japanese atopic dermatitis patients.

## Key findings

- Crawling itch is associated with IL-31 levels but not TARC.
- Stinging and stabbing sensations correlate with TARC but not IL-31.
- Stinging, stabbing, and burning sensations are linked to clinical measures and PROMs.

## Abstract

To elucidate the relationships among various itch qualities, blood biomarkers, and patient-reported outcome measures (PROMs) in atopic dermatitis (AD), we characterized 10 qualities of itch (QoIs) in adult Japanese patients with AD and examined their associations with blood biomarkers as well as objective and subjective clinical measures.

The QoI was assessed by a translated 10-item questionnaire. The relationship among each QoI and blood biomarkers (including interleukin [IL]-31, thymus and activation-regulated chemokine [TARC], and lactate dehydrogenase levels; differential white blood cell counts, including eosinophil, basophil, and neutrophil relative counts; and total immunoglobulin E levels); PROMs, such as visual analog scale and patient-oriented eczema measure; and objective measures, such as eczema area and severity index, was evaluated.

Patients with AD frequently suffered from a sensation similar to crawling like ant (crawling) and stinging and burning sensations. Crawling was positively correlated with serum IL-31 levels but not serum TARC level. Stinging and stabbing sensations were positively correlated with serum TARC level but not with serum IL-31 levels. Stinging, stabbing, and burning sensations were correlated with PROMs and eczema area and severity index. Our limitation is that other cytokines, such as IL-4 and IL-13, were not measured.

The QoI in Japanese patients with AD could be classified into IL-31-related and TARC-related types. Our findings suggest relationships between crawling and IL-31 and between stinging and stabbing and TARC in Japanese patients with AD.

## Linked entities

- **Diseases:** atopic dermatitis (MONDO:0004980)

## Full-text entities

- **Genes:** CCL17 (C-C motif chemokine ligand 17) [NCBI Gene 6361] {aka A-152E5.3, ABCD-2, SCYA17, TARC}, IL13 (interleukin 13) [NCBI Gene 3596] {aka IL-13, P600}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, Il31 (interleukin 31) [NCBI Gene 76399] {aka 1700013B14Rik}, Ccl17 (C-C motif chemokine ligand 17) [NCBI Gene 20295] {aka Abcd-2, Scya17, Scya17l, Tarc}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, LORICRIN (loricrin cornified envelope precursor protein) [NCBI Gene 4014] {aka LOR}, IL31 (interleukin 31) [NCBI Gene 386653] {aka IL-31}, IGHE (immunoglobulin heavy constant epsilon) [NCBI Gene 3497] {aka IgE}, Il31ra (interleukin 31 receptor A) [NCBI Gene 218624] {aka CRL3, GLM-R, GPL, Glmr, NR10}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, FLG (filaggrin) [NCBI Gene 2312] {aka ATOD2, FLG-1, FLG1}
- **Diseases:** papulation (MESH:D000169), hypersensitivity (MESH:D004342), Dryness (MESH:D014987), prurigo nodularis (MESH:D011536), neuropathic pain (MESH:D009437), EASI (MESH:D045169), PBC (MESH:D008105), AD (MESH:D003876), erythema (MESH:D004890), POEM (MESH:D004485), arthritis (MESH:D001168), chronic liver dysfunction (MESH:D058625), sunburn (MESH:D013471), allergic rhinitis (MESH:D065631), dermatitis (MESH:D003872), induration (MESH:D010411), atopic disorders (MESH:D006969), urticaria (MESH:D014581), Bleeding (MESH:D006470), Itch (MESH:D011537), systemic diseases (MESH:D034721), psoriasis (MESH:D011565), arthritic pain (MESH:D010146), skin diseases (MESH:D012871), cholestatic and metabolic liver diseases (MESH:D008107), inflammation (MESH:D007249), neuroinflammatory diseases (MESH:D000090862), chronic-kidney-disease (MESH:D051436), nonalcoholic steatohepatitis (MESH:D065626)
- **Chemicals:** capsaicin (MESH:D002211), chloroquine (MESH:D002738), zymosan (MESH:D015054), histamine (MESH:D006632)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12945512/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12945512/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC12945512/full.md

---
Source: https://tomesphere.com/paper/PMC12945512